Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

MLA

Thouvenin, Jonathan, et al. “Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.” The Oncologist, vol. 27, no. 12, Dec. 2022, pp. 1041–47. EBSCOhost, https://doi.org/10.1093/oncolo/oyac158.

APA

Thouvenin, J., Alhalabi, O., Carlo, M., Carril-Ajuria, L., Hirsch, L., Martinez-Chanza, N., Négrier, S., Campedel, L., Martini, D., Borchiellini, D., Chahoud, J., Lodi, M., Barthélémy, P., Hasanov, E., Hahn, A. W., Gil, T., Viswanathan, S. R., Bakouny, Z., Msaouel, P., … Malouf, G. G. (2022). Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas. The Oncologist, 27(12), 1041–1047. https://doi.org/10.1093/oncolo/oyac158

Chicago

Thouvenin, Jonathan, Omar Alhalabi, Maria Carlo, Lucia Carril-Ajuria, Laure Hirsch, Nieves Martinez-Chanza, Sylvie Négrier, et al. 2022. “Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.” The Oncologist 27 (12): 1041–47. doi:10.1093/oncolo/oyac158.